Medtronic announced that the first two patients have been enrolled in the DIAM spinal stabilization trials. This clinical trial will study the safety and effectiveness of the device for treatment of spinal stenosis (the gradual narrowing of the spinal canal) at a single level between L2-L5. See back.com for more details.
First Patients Enrolled in DIAM trial
December 18th, 2006 · No Comments
Tags: News
ImmunoCellular Therapeutics
December 7th, 2006 · No Comments
LOS ANGELES–(BUSINESS WIRE)–ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) (“ICT”) is pleased to announce today that Robert Martuza, M.D., has become a member of the Company’s Board of Directors.
Dr. Martuza is Chief of Neurosurgery and director of the Stephen E. and Catherine Pappas Center for Neuro-Oncology at Massachusetts General Hospital and Higgins Professor of Neurosurgery at Harvard Medical […]
Tags: News
iPlan Neuroradiology from BrainLab
November 29th, 2006 · No Comments
BrainLAB has announced availability of iPlan Neuroradiology combines a wide range of image analysis tools within one system, including image fusion of different modalities and segmentation algorithms for critical brain anatomy functionality. Functional data analysis is further enhanced with advanced fMRI (BOLD) and diffusion tensor imaging (DTI) algorithm capabilities.
With further interest developing in the […]
Tags: News
Kyphon
January 11th, 2006 · No Comments
…releases 2 year kyphoplasty data.
Study Details In the study, 117 consecutive patients (151 spinal fractures) treated with balloon kyphoplasty were assessed for change in spinal deformity, pain scores, analgesic usage and ambulatory status…..
Among the 77 patients followed for two years, two percent could walk independently prior to treatment, and 81 percent required narcotic analgesics […]
Tags: News